We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
+13.47%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$377M
AUM Growth
+$41.9M
Cap. Flow
+$7.27M
Cap. Flow %
1.93%
Top 10 Hldgs %
20.9%
Holding
176
New
29
Increased
67
Reduced
61
Closed
11

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$8.67M
2
CGNX icon
Cognex
CGNX
+$6.97M
3
CRH icon
CRH
CRH
+$5.6M
4
LIN icon
Linde
LIN
+$5.07M
5
JCI icon
Johnson Controls International
JCI
+$3.32M

Top Sells

Rank Stock Value
1
VMC icon
Vulcan Materials
VMC
+$5.18M
2
ROK icon
Rockwell Automation
ROK
+$4.19M
3
APG icon
APi Group
APG
+$4.13M
4
CLH icon
Clean Harbors
CLH
+$4.11M
5
WCC
WESCO International
WCC
+$3.88M

Sector Composition

Rank Sector Weight
1 Industrials 38.16%
2 Healthcare 30.66%
3 Technology 10.25%
4 Utilities 8.88%
5 Materials 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEYS icon
126
Keysight
KEYS
$54B
$635K 0.17%
+3,875
New +$591K
JPM icon
127
JPMorgan Chase
JPM
$907B
$630K 0.17%
+2,173
New +$555K
AAPG
128
Ascentage Pharma
AAPG
$1.75B
$610K 0.16%
+15,495
New +$408K
GH icon
129
Guardant Health
GH
$20.7B
$591K 0.16%
11,350
+1,190
+12% +$53.1K
ICLR icon
130
Icon
ICLR
$13.1B
$576K 0.15%
+3,959
New +$562K
ARWR icon
131
Arrowhead Research
ARWR
$10.5B
$559K 0.15%
35,359
+5,466
+18% +$78.4K
AKRO
132
DELISTED
Akero Therapeutics
AKRO
$546K 0.15%
10,239
-1,539
-13% -$69.9K
MDGL icon
133
Madrigal Pharmaceuticals
MDGL
$12.8B
$545K 0.14%
1,801
-477
-21% -$142K
SRRK icon
134
Scholar Rock
SRRK
$6.33B
$537K 0.14%
+15,153
New +$476K
ARVN icon
135
Arvinas
ARVN
$517M
$531K 0.14%
72,114
+33,799
+88% +$249K
VKTX icon
136
Viking Therapeutics
VKTX
$4.31B
$524K 0.14%
19,755
+524
+3% +$13.8K
MIRM icon
137
Mirum Pharmaceuticals
MIRM
$7.25B
$506K 0.13%
9,947
-1,485
-13% -$66.1K
NBIX icon
138
Neurocrine Biosciences
NBIX
$17.2B
$491K 0.13%
3,904
– –
RCUS icon
139
Arcus Biosciences
RCUS
$3.44B
$486K 0.13%
59,662
+44,411
+291% +$379K
TEVA icon
140
Teva Pharmaceuticals
TEVA
$37.3B
$484K 0.13%
28,861
– –
INSM icon
141
Insmed
INSM
$23.5B
$480K 0.13%
4,765
-4,416
-48% -$338K
GPCR icon
142
Structure Therapeutics
GPCR
$3.45B
$475K 0.13%
22,880
+290
+1% +$6.38K
ILMN icon
143
Illumina
ILMN
$28.2B
$461K 0.12%
4,835
+1,322
+38% +$107K
WST icon
144
West Pharmaceutical
WST
$25.3B
$433K 0.11%
1,977
-292
-13% -$62.4K
BDX icon
145
Becton Dickinson
BDX
$43.6B
$420K 0.11%
2,438
+186
+8% +$34.1K
REPL icon
146
Replimune Group
REPL
$859M
$380K 0.1%
40,906
+3,384
+9% +$29.5K
SYK icon
147
Stryker
SYK
$123B
$355K 0.09%
898
+100
+13% +$37.4K
SDGR icon
148
Schrodinger
SDGR
$1.14B
$352K 0.09%
17,493
+1,036
+6% +$23.7K
RLAY icon
149
Relay Therapeutics
RLAY
$4.34B
$336K 0.09%
97,150
+8,040
+9% +$23.9K
CGEM icon
150
Cullinan Oncology
CGEM
$1.09B
$321K 0.09%
42,692
+3,528
+9% +$28.3K
4 5
6
7 8

Similar funds

DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $3.08B AUM 12.02% 1-Year Est. Return

Tema ETFs's Q2 2025 Portfolio in Review

As of Q2 2025, Tema ETFs held 176 positions worth $377M, up 13% from $335M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tema ETFs's Q2 2025 filing shows 29 new, 67 increased, 61 reduced and 11 closed positions. Its largest new stake was Eaton: 28,145 shares worth $10M. The largest sale was Vulcan Materials, an estimated $5.18M.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, down from 43% a quarter earlier, followed by Healthcare and Technology.

  • Tema ETFs's largest Q2 2025 buy was Eaton: 28,145 shares worth $10M.
  • Tema ETFs added most to Entergy in Q2 2025, an estimated $1.59M increase.
  • Tema ETFs's biggest Q2 2025 reduction was Vulcan Materials, cutting an estimated $5.18M.
  • Tema ETFs fully exited WESCO International in Q2 2025, selling an estimated $3.88M.
  • Tema ETFs's ten largest holdings make up 21% of its $377M portfolio in Q2 2025.
  • Tema ETFs opened 29 new positions and closed 11 in Q2 2025.
  • Tema ETFs's portfolio value rose 13% quarter-over-quarter to $377M.

Based on Tema ETFs's 13F filing for Q2 2025, filed 13 Aug 2025.